CERo Therapeutics Holdings, Inc. (CERO) analyst actions
Rating and price-target actions on CERO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CERO overview →
2 measured CERO analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| CERo Therapeutics Initiates Second Cohort of Phase 1 Clinical Trial of CER-1236 in AML with Patient Receiving Significant Increase in Dosing | Press release | -6.26% | -6.42% | |
| CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement with Contract Research Organization CellCarta to Manage Translational Assays | Press release | +0.00% | +1.39% |
Keep exploring
More CERO: earnings → · SEC filings → · CERO overview →